Research is being conducted on the role of natural killer cells in cancer therapy, with studies exploring their potential in treating various types of cancer. Advances in natural killer cell immunotherapy are being reported, including the use of chimeric antigen receptor-natural killer cell therapy and receptor engineering. The field appears to be expanding, with investigations into the use of natural killer cells in treating specific cancers, such as ovarian and prostate cancer.